Journal issues > Issue 2, May 2013 > Statins and cancer

Statins and cancer

Summary

Although proliferating malignant cells consume cholesterol, this may not completely explain the observed inverse relation between plasma cholesterol levels and the incidence of cancer. Results of studies and meta-analysis, investigating possible adverse effects of cholesterol-lowering therapy did not disclose any consistent promoting or preventive activity of statins on the incidence of frequently occurring cancers. However, statin use may reduce the rate of dedifferentiation and recurrence of established prostate and breast cancer. Furthermore, lipoprotein (-like) ligands for low- and high density lipoprotein receptors on tumour cells can serve as carriers for targeted anti-cancer therapies.

(BELG J MED ONCOL 2013:7(2):46–49)

To read the full artice you have the following options:

* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Oncology/Hemato-oncology in Belgium and Luxembourg with prescription authorisation)

Purchase this article for €3.03

** (for healthcare professionals with prescribing authorisation working outside the field of Oncology/Hemato-oncology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Oncology/Hemato-oncology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)

Top